The largest database of trusted experimental protocols

341 protocols using peg400

1

Preparation and Analysis of PEG 400 Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
PEG
400, acetonitrile,
and methanol were procured from Sigma-Aldrich (Mumbai, India), CDH,
and Spectrochem (India), respectively. Sodium acetate and acetic acid
were procured from Sigma-Aldrich, Mumbai, India. The acetate buffer
was freshly prepared for dissolution and analytical studies. Solvents
were of analytical reagent grade (AR). Millipore water was used as
an aqueous medium for varied PEG 400 to water ratio in the mixture.
+ Open protocol
+ Expand
2

LPS-Induced Cardiac Dysfunction: ATX Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cardiac dysfunction was induced by an intraperitoneal injection of LPS (10 mg/kg; cat. no. L2880; Sigma-Aldrich; Merck KGaA) for 24 h, as previously described (14 (link)). ATX (40 mg/kg; cat. no. SML0982; Sigma-Aldrich; Merck KGaA) dissolved in polyethylene glycol 400-N, N-dimethylacetamide (PEG400; 1:1 v/v; cat. no. 91863; Sigma-Aldrich; Merck KGaA) was administered to the mice in the LPS + ATX group 30 min after LPS administration for 24 h. The mice in the control and LPS groups were administered an equivalent volume of the vehicle (PEG400; 1:1 v/v; cat. no. 91863; Sigma-Aldrich; Merck KGaA). The health, behavior and death of mice were monitored every 6 h following LPS administration. In the LPS and LPS + ATX groups, 8 and 3 mice died, respectively, of severe infection following LPS treatment. All the surviving animals were anesthetized with pentobarbital solution (50 mg/kg) via an intraperitoneal injection 24 h after LPS treatment. Following anesthesia, 0.5 ml blood was collected from the mice by eyeball enucleation; which prompted two mice to die from severe anemia. To isolate myocardial tissue, mice were sacrificed by cervical dislocation. Following a 2 min observation, no respiration and corneal reflex in the mice confirmed death. The heart tissue was isolated post-mortem and stored in 4% paraformaldehyde or at −80°C.
+ Open protocol
+ Expand
3

Triclosan Induces Acute Colitis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 male mice (six-week-old, Charles River, Wilmington, MA) were randomly divided into control and treatment groups (n = 8 for each group). The mice in the control group were treated with a modified AIN-93G diet (Table S1) containing 0.5% v/w polyethylene glycol 400 (PEG 400, EMD Millipore, Billerica, MA), and the mice in the treatment group were treated with the diet containing TCC (99%, Sigma-Aldrich, St. Louis, MO) dissolved in PEG 400 during the whole experiment. After 3 weeks, the mice were treated with 2% DSS (36–50 kDa, MP Biomedicals, Solon, OH) in drinking water to induce acute colitis. After 9 days, the mice were sacrificed, and the blood and colon tissues were collected for analysis.
+ Open protocol
+ Expand
4

Evaluating Montelukast's Effect on Dexamethasone-Induced Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old male C57BL/6N mice were obtained from Koatech (Pyeongtaek, Korea). All animal studies were approved by the Use Committee of the Dongguk University (IACUC-2021-10) and performed in accordance with the guidelines for Institutional Animal Care. The mice were maintained under controlled conditions at 22 ± 3 °C and a 12 h/12 h light/dark cycle. They were given free access to food and water. After adaption for one week, all the mice were randomly divided into four groups (n = 8 animals per group) as follows: (I) the normal group was administered 0.9% saline, intraperitoneal injection of the same volume of PEG400 (Cat. 25322-68-3, Sigma-Aldrich, St. Louis, MO, USA) as DEX group subsequently (Nor group); (II) the dexamethasone was dissolved into PEG400 [13 (link)] and intraperitoneally injected DEX 10 mg/kg, then administrated 0.9% saline once a day for 10 days (DEX group); MON was dissolved into 0.9% saline. (III) One group was injected DEX and administered 40 mg/kg MON (MON40 group); and (IV) one group was injected DEX and administered 80 mg/kg MON (MON80 group). Two different concentrations of MON (40 and 80 mg/kg) were administered once a day. During treatment with drugs, the body weights of mice were measured once three days.
+ Open protocol
+ Expand
5

Pharmacokinetics of Molnupiravir and Teriflunomide

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old Syrian Gold hamsters (72–96 g) were obtained from Janvier Labs (Saint Berthevin, France). The animals received either 150 mg/kg Molnupiravir (MedChemExpress LLC) twice daily or 20 mg/kg/day Teriflunomide (Biozol) via oral application using a feeding pipet (n = 3 per group). Teriflunomide was formulated in 20% PEG400 (Roth), 2% Tween-80 (Sigma Aldrich), 39% peanut oil (Braendle) and 39% strawberry syrup (Yo); Molnupiravir was formulated in 10% PEG400, 2% Tween-80, 44% water and 44% strawberry syrup. Molnupiravir was given twice daily with 8 h between first and second treatment each day in an application volume of 4 mL/kg. Formulations were freshly prepared before every application. At day one, PK samples were taken 0.5, 1, 2, 4, 8 and 24 h after the first dose. Compound concentrations were analyzed in whole blood using liquid chromatography-mass spectrometry. For Molnupiravir, its active metabolite, EIDD-1931/NHC, was measured.
+ Open protocol
+ Expand
6

Synthesis and Characterization of SARS-CoV-2 Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
PF-07321332 was synthesized at TCG Lifesciences (India) and Wuxi (USA). In addition, a 1:1 MTBE solvate form of PF-07321332 was kindly provided by Pfizer. GS-441524 (the parent nucleoside analog of remdesivir) was purchased from Carbosynth (United Kingdom). For in vitro assays, compounds were dissolved in analytical grade dimethyl sulfoxide (DMSO) to 10 mM stock solution. For in vivo studies, the Beta variant efficacy studies were performed with both PF-07321332 (TCG Lifesciences) and the MTBE solvate form from Pfizer. PF-07321332 (TCG Lifesciences) was formulated as 40 mg/ml in a vehicle containing 40% PEG400 (Sigma) in sterile distilled water. The MTBE solvate form (Pfizer) was formulated as 40 mg/ml suspension in 2% (v/v) Tween80 in 98% (v/v) of 0.5% (w/v) methylcellulose by geometric dilution. PF-07321332 (from Wuxi) was used only in the delta variant hamster study and it was formulated as 40 mg/ml in a vehicle containing 60% PEG400 (Sigma) in sterile distilled water. In these studies, the crystalline form of the active product ingredient (API) was characterized by differential scanning calorimetry (DSC) (data not shown). X-ray powder diffraction (XRPD) would be however required to fully characterize the crystalline form of each API used in in vivo studies.
+ Open protocol
+ Expand
7

Unilateral Ureteric Obstruction in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old female C57BL/6 mice were subjected to a dorsolateral incision after proper anesthesia. Then the left ureter was permanently ligated as described previously [24 (link)]. Mice were then divided into two groups: (1) those treated with NSC828779 (daily dose of 10 mg/kg body weight, i.p.) dissolved in polyethylene glycol 400 (PEG 400) (Sigma-Aldrich, St. Louis, MO, USA) (UUO + NSC828779) one day after UUO induction, and (2) those that received vehicle (PEG 400) only, to serve as disease controls. Sham-operated mice, which received an identical surgical procedure, but without ureteric ligation (sham controls), and sham-operated mice treated with NSC828779 (sham + NSC828779) served as controls. Seven mice per group was used. At day 7 or 14, mice were euthanized, and their renal tissues and pelvic urine were collected [25 (link)]. All animal experiments were performed with approval of the Institutional Animal Care and Use Committee of the National Defense Medical Center, Taiwan, in compliance with the NIH Guide for the Care and Use of Laboratory Animals.
+ Open protocol
+ Expand
8

Enhancing ACY-1215 Bioavailability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reagent 2-(diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl) pyrimidine-5-carboxamide (ACY-1215) was purchased from Chemietek (Indianapolis, IN). ACY-1215 (ACY) was first dissolved in DMSO (Sigma–Aldrich, St. Louis, MO) and then in culture medium (1–2 µM) for cell culture. Because PEG-400 enhances the bioavailability of ACY, it was dissolved in PEG-400 (Sigma–Aldrich) and diluted with sterile water. ACY was administrated to mice by gavage.
+ Open protocol
+ Expand
9

In Vivo Bioluminescence Imaging of Luciferin and NCL Probe

Check if the same lab product or an alternative is used in the 5 most similar protocols
Potassium salt of D-luciferin (Intrace Medical) was dissolved in PBS (pH 7.2), solution was filter sterilized through 0.22 μm filter, aliquoted and kept at –20°C. NCL probe was dissolved in PEG400 (Sigma-Aldrich) and diluted with sterile PBS (pH 7.2) 1:5 (20% (v/v) of PEG400 in the total volume of 200 μL), fresh solution was prepared before every imaging. The dose of NCL probe (1.9 mg/mouse) was equivalent (4.7 μmol) to the dose of luciferin (1.5 mg/mouse). Mice were anesthetized prior to injection and during imaging via inhalation of isoflurane (Piramal Critical Care, Inc). When the total photon flux over 1 h from the mice imaged with luciferin reached 1 × 108, the mice entered the experiment. On day 1 of the experiment all mice were injected IP with luciferin (1.5 mg/mouse in 50 μL of PBS) and bioluminescence was acquired immediately every 1 min for 1 h with the auto-exposure mode. On day 2 of the experiment (24 h after the luciferin imaging) all mice were injected IP with NCL probe (1.9 mg/mouse in 200 μL of PBS containing 20% (v/v) PEG400) and bioluminescence was acquired immediately every 1 min for 1 h with the auto-exposure mode.
+ Open protocol
+ Expand
10

Drug Formulation and Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Napabucasin, panobinostat, and quisinostat were purchased from Selleckchem and A1331852 and Navitoclax from Chemietek, diluted in DMSO to make stock solutions, aliquoted and stored at −80C. Napabucasin was formulated by heating to 50C for 10 minutes and then sequentially adding 45% PEG300 (Sigma), 5% Tween80 (Sigma) and 45% sterile water, with vortexing after adding each component (Selleckchem). panobinostat was formulated by sequentially adding 48% PEG300 (Sigma), 2% Tween80 (Sigma) and 48% sterile water, with vortexing after adding each component (Selleckchem). quisinostat was formulated in 10% hydroxypropyl-b-cyclodextrin (Sigma), 25 mg/ml mannitol (Sigma), in sterile water(45 (link)). A1331852 was formulated by sequentially adding 10% Ethanol (Fisher), 60% Phosal 50 PG (Lipoid), and 30% PEG400 (Sigma), and vortexing (MedChemExpress). Navitoclax was formulated in 10% ethanol (Fisher), 30% PEG400 (Sigma), and 60% Phosal 50 PG (Lipoid), with vortexing after adding each component (MedChemExpress). Sorafenib was formulated in 90% corn oil (Selleckchem) with vortexing (MedChemExpress). Working solutions were made fresh prior to administration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!